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A 26-year-old male born of a non-consanguineous marriage
with normal birth and developmental history presented with abnor-
mal movements for the last 15 years. He first noticed changes in
his handwriting. The movements were jerky, non-stereotyped, and
were associated with violent flinging movements. They were not
preceded by any premonitory urge and were only partially sup-
pressible. The movements gradually progressed to involve the face
and neck, and, over the next 5 years, became generalized. His
parents also complained of behavioral disturbances such as hyper-
activity, aggressiveness, and obsessive-compulsive behavior. There was
no history of cognitive decline, psychosis, seizures, or myoclonic
jerks. Family history was non-contributory. There was no history of
rheumatic fever, vasculitis, or exposure to toxins. The patient suf-
fered frequent throat infections until the age of 5 years. He had been
previously prescribed multiple medications, without significant impro-
vement (tetrabenazine, haloperidol, valproate, clonazepam in various
combinations).
General physical examination was normal. He was alert, oriented to
time, place, and person. Pertinent examination findings included unclear
speech and generalized hypotonia. Deep tendon reflexes were 2+ with
bilateral flexor plantar response and no cerebellar signs. The movement
disorder is depicted in the Video 1. Work-up for his generalized chorea
was undertaken. His C-reactive protein and antistreptolysin (ASO)
titers were normal. Vasculitic markers Rheumatoid factor (RF/
ANA/dsDNA/C3/c-ANCA/p-ANCA/anti-Ro/La/anticardiolipin
antibodies/APLA/LA), 24-hour urinary copper, ceruloplasmin levels,
PBF for acanthocytes, TSH, anti-TPO antibodies, anti-TTG,
alpha-fetoprotein, and vitamin E levels were all within normal
limits. Antibody testing for paraneoplastic syndrome was negative.
Previously performed normal investigations included tandem mass
spectrometry for aminoacidopathies, urine for propionic aciduria,
genetic testing for DYT1 mutation, and genetic testing for Huntington’s
disease (CAG repeats- 25). Magnetic resonance imaging brain was
normal. Fludeoxyglucose positron emission tomography (PET) brain
revealed mild hypermetabolism in the bilateral caudate nuclei
(Figure 1). Echocardiography revealed mild thickening of the mitral
and aortic leaflets. In view of longstanding generalized chorea with
the suggestion of mitral valve thickening on echocardiography and
striatal hypermetabolism on the PET scan, the patient was diagnosed
as a case of Sydenham’s chorea. Whole-exome sequencing did not
reveal any pathogenic variation. Finally, antineuronal antibodies
(Cunningham panel) were markedly elevated: dopamine D1, 16,000
(normal range 500–2000); lysoganglioside, 320 (normal range
80–320); tubulin, 4,000 (normal range 250–1,000), CaM kinase II,
120 (normal range 53–130). In view of these findings, the patient was
started on methylprednisolone therapy and intravenous immunoglo-
bulin. However, the patient showed only a marginal improvement
in the severity of chorea. The hyperkinetic movements decreased
in amplitude. His gait improved, and violent flinging movements of
the arms also decreased in intensity. Presently, the patient is on perio-
dic cycles of methylprednisolone and intravenous immunoglobulin
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therapy. He is now able to feed and dress by himself, which he was
unable to do previously.
Discussion
Sydenham’s chorea is a late manifestation of rheumatic fever and
comprises chorea, tics, behavioral abnormalities, dysarthria, motor
impersistence, and gait disturbances.1 It is usually a self-limited con-
dition that improves in 2–6 months. Persistent Sydenham’s chorea is
described in 50% of cases lasting more than 2 years and is more
common in women who have severe disease, with the presence of
severe carditis, and with generalized chorea.2 Our patient is unique
because his chorea has persisted for more than 15 years from its onset
and there was only mild asymptomatic cardiac involvement. The pro-
posed pathophysiology of Sydenham’s chorea involves the mechanism
of molecular mimicry. Current literature highlights the role of basal
ganglia autoantibodies/antineuronal antibodies in Sydenham’s chorea.3
These antineuronal antibodies comprise dopamine 1 receptor (D1),
dopamine 2 receptor (D2), lysoganglioside GM1, and beta-tubulin.
Ben-Pazi et al.4 have demonstrated significantly higher anti-D1R
and anti-D2R autoantibodies in patients with Sydenham’s chorea
than controls and their correlation with neuropsychiatric symp-
toms and they postulated that these autoantibodies lead to receptor
imbalance and induce greater sensitivity to dopamine signaling. These
antibodies are, however, not specific for Sydenham’s chorea and can
also occur in other conditions such as PANDAS, Tourette’s syndrome,
adult-onset tic disorders, obsessive compulsive disorders, and others.5,6
The presence of these antibodies in our patient supports the diagnosis of
Sydenham’s chorea.
PET findings in Sydenham’s chorea reveal hypermetabolism in
the basal ganglia.7 They are usually present in the acute phase and
disappear with remission. Our patient also showed increase striatal
glucose consumption, which may suggest ongoing inflammation and
active disease. This is also emphasized by the presence of high titers of
basal ganglia autoantibodies.
Treatment with intravenous immunoglobulin or plasma exchange
has been found to be superior to corticosteroids in decreasing
mean chorea severity scores. Our patient showed only a marginal
decrease in the severity of chorea after intravenous immunoglobulin
therapy.
To conclude, we present an unusual presentation of Sydenham’s
chorea lasting more than 15 years and highlight the utility of anti-
neuronal antibodies in such a scenario.
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Figure 1. FDG PET Scan. FDG PET scan showing mild hypermetabolism in
bilateral caudate nuclei.
Video 1. Video of Chorea. Video demonstrates presence of generalized
chorea with significant impairment of gait.
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